Inventor · disambiguated record
Steven Ronkin
Also filed as: RONKIN STEVEN · RONKIN STEVEN M · RONKIN STEVEN MICHAEL
43 granted patents·11 pending applications·1,472 citations·filing 1996–2024
98Inventor score
Top patents by PatentIndex Score
54 records- 0199US6054472AInhibitors of IMPDH enzymeVERTEX PHARMA·Filed 1997·Granted Apr 25, 2000·242 cites·12 claims
- 0298US6653309B1Inhibitors of IMPDH enzyme technical field of the inventionVERTEX PHARMA·Filed 2000·Granted Nov 25, 2003·131 cites·19 claims
- 0398US5807876AInhibitors of IMPDH enzymeVERTEX PHARMA·Filed 1996·Granted Sep 15, 1998·304 cites·21 claims
- 0497US6498178B2Inhibitors of IMPDH enzymeVERTEX PHARMA·Filed 2001·Granted Dec 24, 2002·174 cites·45 claims
- 0596US6541496B1Inhibitors of IMPDH enzymeVERTEX PHARMA·Filed 2000·Granted Apr 1, 2003·80 cites·12 claims
- 0696US6344465B1Inhibitors of IMPDH enzymeVERTEX PHARMA·Filed 1997·Granted Feb 5, 2002·186 cites·9 claims
- 0795US9359380B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2014·Granted Jun 7, 2016·19 cites·25 claims
- 0895US9340557B2Substituted quinoxaline DNA-PK inhibitorsVERTEX PHARMA·Filed 2014·Granted May 17, 2016·19 cites·26 claims
- 0993US10786512B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2019·Granted Sep 29, 2020·3 cites·8 claims
- 1093US8067606B2Gyrase inhibitors and uses thereofCHARIFSON PAUL·Filed 2009·Granted Nov 29, 2011·14 cites·24 claims
- 1192US11440907B1Antiproliferation compounds and uses thereofMERCK PATENT GMBH·Filed 2020·Granted Sep 13, 2022·3 cites·25 claims
- 1292US10973830B2Substituted quinoxaline DNA-PK inhibitorsVERTEX PHARMA·Filed 2019·Granted Apr 13, 2021·3 cites·23 claims
- 1391US11884672B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2020·Granted Jan 30, 2024·4 cites·11 claims
- 1491US8193352B2Gyrase inhibitors and uses thereofCHARIFSON PAUL·Filed 2009·Granted Jun 5, 2012·11 cites·18 claims
- 1590US9987284B2Substituted benzooxadiazole DNA-PK inhibitorsVERTEX PHARMA·Filed 2016·Granted Jun 5, 2018·5 cites·23 claims
- 1689US12331057B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2023·Granted Jun 17, 2025·1 cites·11 claims
- 1789US10258627B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2017·Granted Apr 16, 2019·4 cites·19 claims
- 1889US8034832B2Gyrase inhibitors and uses thereofVERTEX PHARMA·Filed 2009·Granted Oct 11, 2011·13 cites·7 claims
- 1989US7989498B2Inhibitors of IMPDH enzymeVERTEX PHARMA·Filed 2003·Granted Aug 2, 2011·19 cites·1 claims
- 2089US7582641B2Gyrase inhibitors and uses thereofVERTEX PHARMA·Filed 2004·Granted Sep 1, 2009·21 cites·28 claims
- 2189US6608087B1Gyrase inhibitors and uses thereofVERTEX PHARMA·Filed 2002·Granted Aug 19, 2003·29 cites·13 claims
- 2288US8188095B2Gyrase inhibitors and uses thereofCHARIFSON PAUL·Filed 2008·Granted May 29, 2012·11 cites·6 claims
- 2388US7618974B2Gyrase inhibitors and uses thereofVERTEX PHARMA·Filed 2004·Granted Nov 17, 2009·21 cites·19 claims
- 2487US8404852B2Gyrase inhibitors and uses thereofCHARIFSON PAUL S·Filed 2011·Granted Mar 26, 2013·10 cites·13 claims
- 2587US7569591B2Gyrase inhibitors and uses thereofVERTEX PHARMA·Filed 2004·Granted Aug 4, 2009·27 cites·2 claims
- 2687US7495014B2Gyrase inhibitors and uses thereofVERTEX PHARMA·Filed 2004·Granted Feb 24, 2009·25 cites·24 claims
- 2787US7329681B2Inhibitors of IMPDH enzymeVERTEX PHARMA·Filed 2005·Granted Feb 12, 2008·8 cites·11 claims
- 2886US12251387B2Substituted quinoxalines and benzo[c][1,2,5]oxadiazoles as DNA-PK inhibitorsVERTEX PHARMA·Filed 2023·Granted Mar 18, 2025·0 cites·20 claims
- 2984US2025188070A1Antiproliferation compounds and uses thereofMERCK PATENT GMBH·Filed 2024·Application pending·0 cites
- 3082US7087642B2Inhibitors of IMPDH enzymeVERTEX PHARMA·Filed 2002·Granted Aug 8, 2006·13 cites·28 claims
- 3181US6967214B2Inhibitors of IMPDH enzymeVERTEX PHARMA·Filed 2003·Granted Nov 22, 2005·12 cites·38 claims
- 3279US10815225B2Antiproliferation compounds and uses thereofMERCK PATENT GMBH·Filed 2019·Granted Oct 27, 2020·1 cites·50 claims
- 3378US7432290B2Inhibitors of IMPDH enzymeVERTEX PHARMA·Filed 2004·Granted Oct 7, 2008·6 cites·2 claims
- 3477US12195453B2Antiproliferation compounds and uses thereofMERCK PATENT GMBH·Filed 2022·Granted Jan 14, 2025·0 cites·24 claims
- 3577US2021236505A1Substituted quinoxaline dna-pk inhibitorsVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3676US11813267B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2020·Granted Nov 14, 2023·0 cites·19 claims
- 3771US6518291B1Inhibitors of IMPDH enzymeVERTEX PHARMA·Filed 1999·Granted Feb 11, 2003·30 cites·12 claims
- 3869US2018311254A1Dna-pk inhibitorsVERTEX PHARMA·Filed 2018·Application pending·0 cites
- 3964US8268873B2Inhibitors of IMPDH enzymeSTAMOS DEAN·Filed 2008·Granted Sep 18, 2012·0 cites·2 claims
- 4064US6930116B2Gyrase inhibitors and uses thereofVERTEX PHARMA·Filed 2003·Granted Aug 16, 2005·1 cites·6 claims
- 4164US2016354381A1Dna-pk inhibitorsObligated Assignee·Filed 2016·Application pending·0 cites
- 4259US5932600AInhibitors of IMPDH enzymeVERTEX PHARMA·Filed 1997·Granted Aug 3, 1999·22 cites·12 claims
- 4354US2013023525A1Gyrase inhibitors and uses thereofVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 4453US2023159502A1Indole derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd)VERTEX PHARMA·Filed 2021·Application pending·0 cites
- 4553US2023339915A1Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 4652US8269013B2Substituted pyrazole inhibitors of c-Met protein kinaseLI PAN·Filed 2010·Granted Sep 18, 2012·0 cites·18 claims
- 4749US8394803B2Gyrase inhibitors and uses thereofCHARIFSON PAUL·Filed 2006·Granted Mar 12, 2013·0 cites·22 claims
- 4849US2003170858A1Gyrase inhibitors and uses thereofFiled 2002·Application pending·0 cites
- 4949US2004048774A1Inhibitors of IMPDH enzymeVERTEX PHARMA·Filed 2003·Application pending·0 cites
- 5046US12005127B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2019·Granted Jun 11, 2024·0 cites·48 claims
Showing the top 50 of 54 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →